AUgmented REality for the Visually Impaired - Part 1 (AUREVI 1)
Retinitis Pigmentosa, Glaucoma
About this trial
This is an interventional basic science trial for Retinitis Pigmentosa
Eligibility Criteria
Inclusion Criteria:
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- The subject is suffering from retinitis pigmentosa or glaucoma with concentric visual field constriction and presents with:
- An acuity in the better eye superior or equal to 1/10 in near vision,
- A binocular field of between 1° and 30°,
- A good central fixation, absence of central scotoma,
- Motor capability for using a computer keyboard with one hand.
Exclusion Criteria:
- The patient is participating in another study
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, or under guardianship
- The patient refuses to sign the consent
- It is impossible to correctly inform the patient
- Subjects with (or evolving toward) a multiple sensory disability, or one including cognitive disorders
Sites / Locations
- CHRU de Nîmes - Hôpital Universitaire Carémea
Arms of the Study
Arm 1
Experimental
The study population
The study population consists of subjects with a concentric constriction of the visual field (retinitis pigmentosa, glaucoma) whose motor capacity allows the use of a computer keyboard with one hand. Subjects are recruited on a voluntary basis, from information disseminated to professionals in the rehabilitation of functional low vision and patient associations, in the Ophthalmology Service of the University Hospital of Nimes and within the ARAMAV Institute. Intervention: Find visual comfort threshold related to light intensity Intervention: Find the size of the visual field Intervention: Effectiveness of brightness control Intervention: Performance of color correction Intervention: Vuzix Wrap 1200DX virtural reality glasses